Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 1 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 169 patents granted in the last 365 days
M.S. Technologies LLC has 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 5 actions are handled by 5 distinct examiners, resulting in a unique examiner for every pending matter. This distribution among 5 distinct examiners prevents any single examiner from having an outsized influence on the portfolio's overall progress.
Despite the variety of examiners, all 5 pending office actions are concentrated within 1 distinct art unit. KUBELIK, ANNE R is the busiest examiner with 1 pending office action. The focus on 1 distinct art unit suggests that while examiners vary, the technical focus of the prosecution remains highly specialized. This concentration in 1 distinct art unit implies a consistent technical environment for all 5 pending office actions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUBELIK, ANNE R | 1 | 75.8% | -1.1% |
| BOGGS, RUSSELL T | 1 | 73.2% | +15.2% |
| KINGDON, CATHY | 1 | 80.3% | +2.6% |
| FAN, WEIHUA | 1 | 83.3% | +12.7% |
| ABRAHAM, AMJAD A | 1 | 31.6% | +35.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18805213 | SOYBEAN CULTIVAR 08064455 | FAN, WEIHUA | 8d |
| 19257176 | SOYBEAN CULTIVAR 07230211 | KUBELIK, ANNE R | — |
| 19060138 | SOYBEAN CULTIVAR 00540608 | KINGDON, CATHY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18370794 | SOYBEAN CULTIVAR 28030716 | ABRAHAM, AMJAD A | 147d overdue |
| 18805213 | SOYBEAN CULTIVAR 08064455 | FAN, WEIHUA | 8d |
| 19219785 | SOYBEAN CULTIVAR 16430401 | BOGGS, RUSSELL T | — |
| Art Unit | Apps |
|---|---|
| 1663 | 5 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19257176 | SOYBEAN CULTIVAR 07230211 | KUBELIK, ANNE R | 1663 | §101§102§103§112DP | Non-Final OA | — | Pending | Jul 01, 2025 |
| 19219785 | SOYBEAN CULTIVAR 16430401 | BOGGS, RUSSELL T | 1663 | §103§112DP | Non-Final OA | — | Pending | May 27, 2025 |
| 19060138 | SOYBEAN CULTIVAR 00540608 | KINGDON, CATHY | 1663 | §101§112Other | Non-Final OA | — | Pending | Feb 21, 2025 |
| 18805213 | SOYBEAN CULTIVAR 08064455 | FAN, WEIHUA | 1663 | §103§112Other | Non-Final OA | 8d | Pending | Aug 14, 2024 |
| 18370794 | SOYBEAN CULTIVAR 28030716 | ABRAHAM, AMJAD A | 1663 | §112Other | Final Rejection | 147d overdue | Pending | Sep 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialM.S. Technologies LLC has 5 pending office actions as of October 2026, spread across 1 art units and 5 examiners.
Anne R Kubelik has the most, with 1 of M.S. Technologies LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
